Tharimmune Inc (THAR)
0.3651
0.00 (0.00%)
USD |
NASDAQ |
May 17, 16:00
0.3651
0.00 (0.00%)
After-Hours: 20:00
Tharimmune Cash from Financing (TTM): 11.52M for March 31, 2024
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 11.52M |
December 31, 2023 | 11.72M |
September 30, 2023 | 1.870M |
June 30, 2023 | 1.837M |
March 31, 2023 | -0.2583M |
Date | Value |
---|---|
December 31, 2022 | 13.06M |
September 30, 2022 | 13.22M |
June 30, 2022 | 13.90M |
March 31, 2022 | 14.42M |
December 31, 2021 | 0.8987M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-0.2583M
Minimum
Mar 2023
14.42M
Maximum
Mar 2022
8.220M
Average
11.62M
Median
Cash from Financing (TTM) Benchmarks
Ironwood Pharmaceuticals Inc | 257.62M |
Mirum Pharmaceuticals Inc | 324.82M |
NovaBay Pharmaceuticals Inc | 1.313M |
Palatin Technologies Inc | 14.71M |
iBio Inc | 10.68M |